Karuna Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 34.531 million compared to USD 17.825 million a year ago. Net loss was USD 34.416 million compared to USD 17.046 million a year ago. Basic loss per share from continuing operations was USD 1.17 compared to USD 0.65 a year ago. For the half year, operating loss was USD 64.494 million compared to USD 27.880 million a year ago. Net loss was USD 64.913 million compared to USD 25.704 million a year ago. Basic loss per share from continuing operations was USD 2.27 compared to USD 0.98 a year ago.